News | December 16, 2025
Anova launches AI-powered patient matching platform to speed clinical trial enrollment
Clinical trial enrollment has long been a bottleneck in drug development
Clinical trial enrollment has long been a bottleneck in drug development
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
The approval follows strong results from Roche’s phase II NOBILITY and phase III REGENCY studies
HYMPAVZI’s safety profile was generally favorable
LYMPHIR addresses a clear clinical need in a disease with limited treatment options
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
Call it a major milestone in bladder cancer therapy that aims to provide a lifeline for patients who previously had limited options
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
Subscribe To Our Newsletter & Stay Updated
